Global Induced Pluripotent Stem Cells Market Report 2019, Competitive Landscape, Trends and Opportunities
The Induced Pluripotent Stem Cells market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Induced Pluripotent Stem Cells market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Induced Pluripotent Stem Cells market.
Major players in the global Induced Pluripotent Stem Cells market include:
Stemgent
Bone Therapeutics SA
Waisman Biomanufacturing
CellTherapies P/L
Ocata Therapeutics Inc.
Regeneus Ltd.
Organogenesis Inc.
BrainStorm Cell Therapeutics Inc.
Cellular Dynamics
Medipost Co. Ltd.
Fate Therapeutics
Iperian
Axiogenesis
Reprocell
Viacyte
Lonza
Cellectics
System Biosciences
On the basis of types, the Induced Pluripotent Stem Cells market is primarily split into:
Fibroblasts
Amniotic cells
Hepatocytes
Keratinocytes
Others
On the basis of applications, the market covers:
Drug development
Regenerative medicine
Toxicity testing
Academic research
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Induced Pluripotent Stem Cells market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Induced Pluripotent Stem Cells market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Induced Pluripotent Stem Cells industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Induced Pluripotent Stem Cells market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Induced Pluripotent Stem Cells, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Induced Pluripotent Stem Cells in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Induced Pluripotent Stem Cells in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Induced Pluripotent Stem Cells. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Induced Pluripotent Stem Cells market, including the global production and revenue forecast, regional forecast. It also foresees the Induced Pluripotent Stem Cells market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Induced Pluripotent Stem Cells market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Induced Pluripotent Stem Cells market.
Major players in the global Induced Pluripotent Stem Cells market include:
Stemgent
Bone Therapeutics SA
Waisman Biomanufacturing
CellTherapies P/L
Ocata Therapeutics Inc.
Regeneus Ltd.
Organogenesis Inc.
BrainStorm Cell Therapeutics Inc.
Cellular Dynamics
Medipost Co. Ltd.
Fate Therapeutics
Iperian
Axiogenesis
Reprocell
Viacyte
Lonza
Cellectics
System Biosciences
On the basis of types, the Induced Pluripotent Stem Cells market is primarily split into:
Fibroblasts
Amniotic cells
Hepatocytes
Keratinocytes
Others
On the basis of applications, the market covers:
Drug development
Regenerative medicine
Toxicity testing
Academic research
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Induced Pluripotent Stem Cells market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Induced Pluripotent Stem Cells market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Induced Pluripotent Stem Cells industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Induced Pluripotent Stem Cells market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Induced Pluripotent Stem Cells, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Induced Pluripotent Stem Cells in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Induced Pluripotent Stem Cells in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Induced Pluripotent Stem Cells. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Induced Pluripotent Stem Cells market, including the global production and revenue forecast, regional forecast. It also foresees the Induced Pluripotent Stem Cells market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 INDUCED PLURIPOTENT STEM CELLS MARKET OVERVIEW
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells
1.2 Induced Pluripotent Stem Cells Segment by Type
1.2.1 Global Induced Pluripotent Stem Cells Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Fibroblasts
1.2.3 The Market Profile of Amniotic cells
1.2.4 The Market Profile of Hepatocytes
1.2.5 The Market Profile of Keratinocytes
1.2.6 The Market Profile of Others
1.3 Global Induced Pluripotent Stem Cells Segment by Application
1.3.1 Induced Pluripotent Stem Cells Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Drug development
1.3.3 The Market Profile of Regenerative medicine
1.3.4 The Market Profile of Toxicity testing
1.3.5 The Market Profile of Academic research
1.4 Global Induced Pluripotent Stem Cells Market by Region (2014-2026)
1.4.1 Global Induced Pluripotent Stem Cells Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3 Europe Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.1 Germany Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.2 UK Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.3 France Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.4 Italy Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.5 Spain Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.6 Russia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.7 Poland Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.4 China Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.5 Japan Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.6 India Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8 Central and South America Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Induced Pluripotent Stem Cells (2014-2026)
1.5.1 Global Induced Pluripotent Stem Cells Revenue Status and Outlook (2014-2026)
1.5.2 Global Induced Pluripotent Stem Cells Production Status and Outlook (2014-2026)
2 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET LANDSCAPE BY PLAYER
2.1 Global Induced Pluripotent Stem Cells Production and Share by Player (2014-2019)
2.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Player (2014-2019)
2.3 Global Induced Pluripotent Stem Cells Average Price by Player (2014-2019)
2.4 Induced Pluripotent Stem Cells Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Induced Pluripotent Stem Cells Market Competitive Situation and Trends
2.5.1 Induced Pluripotent Stem Cells Market Concentration Rate
2.5.2 Induced Pluripotent Stem Cells Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Stemgent
3.1.1 Stemgent Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.1.3 Stemgent Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.1.4 Stemgent Business Overview
3.2 Bone Therapeutics SA
3.2.1 Bone Therapeutics SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.2.3 Bone Therapeutics SA Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.2.4 Bone Therapeutics SA Business Overview
3.3 Waisman Biomanufacturing
3.3.1 Waisman Biomanufacturing Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.3.3 Waisman Biomanufacturing Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.3.4 Waisman Biomanufacturing Business Overview
3.4 CellTherapies P/L
3.4.1 CellTherapies P/L Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.4.3 CellTherapies P/L Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.4.4 CellTherapies P/L Business Overview
3.5 Ocata Therapeutics Inc.
3.5.1 Ocata Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.5.3 Ocata Therapeutics Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.5.4 Ocata Therapeutics Inc. Business Overview
3.6 Regeneus Ltd.
3.6.1 Regeneus Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.6.3 Regeneus Ltd. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.6.4 Regeneus Ltd. Business Overview
3.7 Organogenesis Inc.
3.7.1 Organogenesis Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.7.3 Organogenesis Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.7.4 Organogenesis Inc. Business Overview
3.8 BrainStorm Cell Therapeutics Inc.
3.8.1 BrainStorm Cell Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.8.3 BrainStorm Cell Therapeutics Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.8.4 BrainStorm Cell Therapeutics Inc. Business Overview
3.9 Cellular Dynamics
3.9.1 Cellular Dynamics Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.9.3 Cellular Dynamics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.9.4 Cellular Dynamics Business Overview
3.10 Medipost Co. Ltd.
3.10.1 Medipost Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.10.3 Medipost Co. Ltd. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.10.4 Medipost Co. Ltd. Business Overview
3.11 Fate Therapeutics
3.11.1 Fate Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.11.3 Fate Therapeutics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.11.4 Fate Therapeutics Business Overview
3.12 Iperian
3.12.1 Iperian Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.12.3 Iperian Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.12.4 Iperian Business Overview
3.13 Axiogenesis
3.13.1 Axiogenesis Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.13.3 Axiogenesis Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.13.4 Axiogenesis Business Overview
3.14 Reprocell
3.14.1 Reprocell Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.14.3 Reprocell Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.14.4 Reprocell Business Overview
3.15 Viacyte
3.15.1 Viacyte Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.15.3 Viacyte Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.15.4 Viacyte Business Overview
3.16 Lonza
3.16.1 Lonza Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.16.3 Lonza Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.16.4 Lonza Business Overview
3.17 Cellectics
3.17.1 Cellectics Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.17.3 Cellectics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.17.4 Cellectics Business Overview
3.18 System Biosciences
3.18.1 System Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.18.3 System Biosciences Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.18.4 System Biosciences Business Overview
4 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Induced Pluripotent Stem Cells Production and Market Share by Type (2014-2019)
4.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Type (2014-2019)
4.3 Global Induced Pluripotent Stem Cells Price by Type (2014-2019)
4.4 Global Induced Pluripotent Stem Cells Production Growth Rate by Type (2014-2019)
4.4.1 Global Induced Pluripotent Stem Cells Production Growth Rate of Fibroblasts (2014-2019)
4.4.2 Global Induced Pluripotent Stem Cells Production Growth Rate of Amniotic cells (2014-2019)
4.4.3 Global Induced Pluripotent Stem Cells Production Growth Rate of Hepatocytes (2014-2019)
4.4.4 Global Induced Pluripotent Stem Cells Production Growth Rate of Keratinocytes (2014-2019)
4.4.5 Global Induced Pluripotent Stem Cells Production Growth Rate of Others (2014-2019)
5 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET ANALYSIS BY APPLICATION
5.1 Global Induced Pluripotent Stem Cells Consumption and Market Share by Application (2014-2019)
5.2 Global Induced Pluripotent Stem Cells Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Drug development (2014-2019)
5.2.2 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Regenerative medicine (2014-2019)
5.2.3 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Toxicity testing (2014-2019)
5.2.4 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Academic research (2014-2019)
6 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Induced Pluripotent Stem Cells Consumption by Region (2014-2019)
6.2 United States Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.3 Europe Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.4 China Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.5 Japan Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.6 India Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
7 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Induced Pluripotent Stem Cells Production and Market Share by Region (2014-2019)
7.2 Global Induced Pluripotent Stem Cells Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
8 INDUCED PLURIPOTENT STEM CELLS MANUFACTURING ANALYSIS
8.1 Induced Pluripotent Stem Cells Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Induced Pluripotent Stem Cells
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Induced Pluripotent Stem Cells Industrial Chain Analysis
9.2 Raw Materials Sources of Induced Pluripotent Stem Cells Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Induced Pluripotent Stem Cells
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET FORECAST (2019-2026)
11.1 Global Induced Pluripotent Stem Cells Production, Revenue Forecast (2019-2026)
11.1.1 Global Induced Pluripotent Stem Cells Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Induced Pluripotent Stem Cells Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Induced Pluripotent Stem Cells Price and Trend Forecast (2019-2026)
11.2 Global Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Induced Pluripotent Stem Cells Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Induced Pluripotent Stem Cells Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells
1.2 Induced Pluripotent Stem Cells Segment by Type
1.2.1 Global Induced Pluripotent Stem Cells Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Fibroblasts
1.2.3 The Market Profile of Amniotic cells
1.2.4 The Market Profile of Hepatocytes
1.2.5 The Market Profile of Keratinocytes
1.2.6 The Market Profile of Others
1.3 Global Induced Pluripotent Stem Cells Segment by Application
1.3.1 Induced Pluripotent Stem Cells Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Drug development
1.3.3 The Market Profile of Regenerative medicine
1.3.4 The Market Profile of Toxicity testing
1.3.5 The Market Profile of Academic research
1.4 Global Induced Pluripotent Stem Cells Market by Region (2014-2026)
1.4.1 Global Induced Pluripotent Stem Cells Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3 Europe Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.1 Germany Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.2 UK Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.3 France Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.4 Italy Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.5 Spain Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.6 Russia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.3.7 Poland Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.4 China Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.5 Japan Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.6 India Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8 Central and South America Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Induced Pluripotent Stem Cells Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Induced Pluripotent Stem Cells (2014-2026)
1.5.1 Global Induced Pluripotent Stem Cells Revenue Status and Outlook (2014-2026)
1.5.2 Global Induced Pluripotent Stem Cells Production Status and Outlook (2014-2026)
2 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET LANDSCAPE BY PLAYER
2.1 Global Induced Pluripotent Stem Cells Production and Share by Player (2014-2019)
2.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Player (2014-2019)
2.3 Global Induced Pluripotent Stem Cells Average Price by Player (2014-2019)
2.4 Induced Pluripotent Stem Cells Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Induced Pluripotent Stem Cells Market Competitive Situation and Trends
2.5.1 Induced Pluripotent Stem Cells Market Concentration Rate
2.5.2 Induced Pluripotent Stem Cells Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 Stemgent
3.1.1 Stemgent Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.1.3 Stemgent Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.1.4 Stemgent Business Overview
3.2 Bone Therapeutics SA
3.2.1 Bone Therapeutics SA Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.2.3 Bone Therapeutics SA Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.2.4 Bone Therapeutics SA Business Overview
3.3 Waisman Biomanufacturing
3.3.1 Waisman Biomanufacturing Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.3.3 Waisman Biomanufacturing Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.3.4 Waisman Biomanufacturing Business Overview
3.4 CellTherapies P/L
3.4.1 CellTherapies P/L Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.4.3 CellTherapies P/L Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.4.4 CellTherapies P/L Business Overview
3.5 Ocata Therapeutics Inc.
3.5.1 Ocata Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.5.3 Ocata Therapeutics Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.5.4 Ocata Therapeutics Inc. Business Overview
3.6 Regeneus Ltd.
3.6.1 Regeneus Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.6.3 Regeneus Ltd. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.6.4 Regeneus Ltd. Business Overview
3.7 Organogenesis Inc.
3.7.1 Organogenesis Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.7.3 Organogenesis Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.7.4 Organogenesis Inc. Business Overview
3.8 BrainStorm Cell Therapeutics Inc.
3.8.1 BrainStorm Cell Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.8.3 BrainStorm Cell Therapeutics Inc. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.8.4 BrainStorm Cell Therapeutics Inc. Business Overview
3.9 Cellular Dynamics
3.9.1 Cellular Dynamics Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.9.3 Cellular Dynamics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.9.4 Cellular Dynamics Business Overview
3.10 Medipost Co. Ltd.
3.10.1 Medipost Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.10.3 Medipost Co. Ltd. Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.10.4 Medipost Co. Ltd. Business Overview
3.11 Fate Therapeutics
3.11.1 Fate Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.11.3 Fate Therapeutics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.11.4 Fate Therapeutics Business Overview
3.12 Iperian
3.12.1 Iperian Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.12.3 Iperian Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.12.4 Iperian Business Overview
3.13 Axiogenesis
3.13.1 Axiogenesis Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.13.3 Axiogenesis Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.13.4 Axiogenesis Business Overview
3.14 Reprocell
3.14.1 Reprocell Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.14.3 Reprocell Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.14.4 Reprocell Business Overview
3.15 Viacyte
3.15.1 Viacyte Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.15.3 Viacyte Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.15.4 Viacyte Business Overview
3.16 Lonza
3.16.1 Lonza Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.16.3 Lonza Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.16.4 Lonza Business Overview
3.17 Cellectics
3.17.1 Cellectics Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.17.3 Cellectics Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.17.4 Cellectics Business Overview
3.18 System Biosciences
3.18.1 System Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Induced Pluripotent Stem Cells Product Profiles, Application and Specification
3.18.3 System Biosciences Induced Pluripotent Stem Cells Market Performance (2014-2019)
3.18.4 System Biosciences Business Overview
4 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Induced Pluripotent Stem Cells Production and Market Share by Type (2014-2019)
4.2 Global Induced Pluripotent Stem Cells Revenue and Market Share by Type (2014-2019)
4.3 Global Induced Pluripotent Stem Cells Price by Type (2014-2019)
4.4 Global Induced Pluripotent Stem Cells Production Growth Rate by Type (2014-2019)
4.4.1 Global Induced Pluripotent Stem Cells Production Growth Rate of Fibroblasts (2014-2019)
4.4.2 Global Induced Pluripotent Stem Cells Production Growth Rate of Amniotic cells (2014-2019)
4.4.3 Global Induced Pluripotent Stem Cells Production Growth Rate of Hepatocytes (2014-2019)
4.4.4 Global Induced Pluripotent Stem Cells Production Growth Rate of Keratinocytes (2014-2019)
4.4.5 Global Induced Pluripotent Stem Cells Production Growth Rate of Others (2014-2019)
5 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET ANALYSIS BY APPLICATION
5.1 Global Induced Pluripotent Stem Cells Consumption and Market Share by Application (2014-2019)
5.2 Global Induced Pluripotent Stem Cells Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Drug development (2014-2019)
5.2.2 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Regenerative medicine (2014-2019)
5.2.3 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Toxicity testing (2014-2019)
5.2.4 Global Induced Pluripotent Stem Cells Consumption Growth Rate of Academic research (2014-2019)
6 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Induced Pluripotent Stem Cells Consumption by Region (2014-2019)
6.2 United States Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.3 Europe Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.4 China Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.5 Japan Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.6 India Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Induced Pluripotent Stem Cells Production, Consumption, Export, Import (2014-2019)
7 GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Induced Pluripotent Stem Cells Production and Market Share by Region (2014-2019)
7.2 Global Induced Pluripotent Stem Cells Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Induced Pluripotent Stem Cells Production, Revenue, Price and Gross Margin (2014-2019)
8 INDUCED PLURIPOTENT STEM CELLS MANUFACTURING ANALYSIS
8.1 Induced Pluripotent Stem Cells Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Induced Pluripotent Stem Cells
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Induced Pluripotent Stem Cells Industrial Chain Analysis
9.2 Raw Materials Sources of Induced Pluripotent Stem Cells Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Induced Pluripotent Stem Cells
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL INDUCED PLURIPOTENT STEM CELLS MARKET FORECAST (2019-2026)
11.1 Global Induced Pluripotent Stem Cells Production, Revenue Forecast (2019-2026)
11.1.1 Global Induced Pluripotent Stem Cells Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Induced Pluripotent Stem Cells Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Induced Pluripotent Stem Cells Price and Trend Forecast (2019-2026)
11.2 Global Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Induced Pluripotent Stem Cells Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Induced Pluripotent Stem Cells Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Induced Pluripotent Stem Cells Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
